Abbott Laboratories buy Argus
Start price
31.01.25
/
50%
€123.82
Target price
31.01.26
-
Performance (%)
-13.62%
Price
11:37
€106.96
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -13.62%. This prediction currently runs until 31.01.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.451% | -2.451% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Argus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat